Insider · CIK 1882672

Sundar G. Raman

Officer at Procter & Gamble PG

Open-market buys0
Open-market sales13
Bought$0
Sold$22.4M

Every trade, with what the company filed around it

Open-market buys and sales as each Form 4 states them, newest first.

How these figures work

Notes on each row are as each Form 4 states them, next to SEC Tracker's own records of the company's filings and other insiders' buys. Holding after is what the filing reports they held after the trade, with the change in their holding.

DateCompanyTradeValueHolding afterNotes
Oct 30, 2026Procter & Gamble PGSold 38,253 sh at $165.00
The filing does not mark this sale as under a Rule 10b5-1 plan. The same day as the company's 8-K filed Oct 30, 2026.
$6.3M47,745 −44%
The filing does not mark this sale as under a Rule 10b5-1 plan. The same day as the company's 8-K filed Oct 30, 2026.
Aug 21, 2026Procter & Gamble PGSold 3,435 sh at $143.02
The filing does not mark this sale as under a Rule 10b5-1 plan. The same day as a Form 144 notice of a planned insider sale filed Aug 21, 2026.
$491K47,745 −7%
The filing does not mark this sale as under a Rule 10b5-1 plan. The same day as a Form 144 notice of a planned insider sale filed Aug 21, 2026.
Aug 21, 2025Procter & Gamble PGSold 9,554 sh at $158.16
The filing does not mark this sale as under a Rule 10b5-1 plan. 7 days after the company's 8-K filed Aug 14, 2025.
$1.5M41,886 −19%
The filing does not mark this sale as under a Rule 10b5-1 plan. 7 days after the company's 8-K filed Aug 14, 2025.
Aug 21, 2024Procter & Gamble PGSold 8,990 sh at $170.59
The filing does not mark this sale as under a Rule 10b5-1 plan.
$1.5M29,915 −23%
The filing does not mark this sale as under a Rule 10b5-1 plan.
May 20, 2024Procter & Gamble PGSold 31,924 sh at $166.95
The filing does not mark this sale as under a Rule 10b5-1 plan.
$5.3M19,042 −63%
The filing does not mark this sale as under a Rule 10b5-1 plan.
Aug 17, 2023Procter & Gamble PGSold 5,736 sh at $152.85
The filing does not mark this sale as under a Rule 10b5-1 plan.
$877K19,037 −23%
The filing does not mark this sale as under a Rule 10b5-1 plan.
Nov 21, 2022Procter & Gamble PGSold 9,922 sh at $145.00
The filing does not mark this sale as under a Rule 10b5-1 plan.
$1.4M12,312 −45%
The filing does not mark this sale as under a Rule 10b5-1 plan.
Nov 10, 2022Procter & Gamble PGSold 5,000 sh at $138.81
The filing does not mark this sale as under a Rule 10b5-1 plan.
$694K12,310 −29%
The filing does not mark this sale as under a Rule 10b5-1 plan.
Nov 10, 2022Procter & Gamble PGSold 9,922 sh at $140.00
The filing does not mark this sale as under a Rule 10b5-1 plan.
$1.4M12,310 −45%
The filing does not mark this sale as under a Rule 10b5-1 plan.
Aug 17, 2022Procter & Gamble PGSold 6,958 sh at $149.33
The filing does not mark this sale as under a Rule 10b5-1 plan.
$1M12,310 −36%
The filing does not mark this sale as under a Rule 10b5-1 plan.
Aug 16, 2022Procter & Gamble PGSold 5,000 sh at $150.00
The filing does not mark this sale as under a Rule 10b5-1 plan.
$750K4,004 −56%
The filing does not mark this sale as under a Rule 10b5-1 plan.
Aug 15, 2022Procter & Gamble PGSold 5,181 sh at $148.01
The filing does not mark this sale as under a Rule 10b5-1 plan.
$767K4,002 −56%
The filing does not mark this sale as under a Rule 10b5-1 plan.
Jul 7, 2022Procter & Gamble PGSold 1,599 sh at $145.12
The filing does not mark this sale as under a Rule 10b5-1 plan.
$232K4,002 −29%
The filing does not mark this sale as under a Rule 10b5-1 plan.

Open-market trades are Form 4 transaction codes P (purchase) and S (sale). Planned sales are those the filing marks as made under a Rule 10b5-1 plan. A P-code buy at the offering price within a day of the company's FWP, 424B prospectus or offering 8-K is marked Bought in the offering and left out of open-market buy counts and cluster buys. Prices and values are as stated in each Form 4. Stock prices aren't shown on this page. Not investment advice.